Evidence map›Paper›PMID 33336306›Full record

ReviewIntensive care medicine experimental2020

H

Tamara Merz, Nicole Denoix, Martin Wepler, Holger Gäßler, David A C Messerer, Clair Hartmann, Thomas Datzmann, Peter Radermacher, Oscar McCook

Abstract readReview
In one paragraph

Review in Intensive care medicine experimental, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Exogenous HOpen medicine (Warsaw, Poland) · 2026
    Article
  2. Review
  3. Article
  4. HBiomolecules · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tamara MerzInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Helmholzstraße 8/1, 89081, Ulm, Germany. tamara.merz@uni-ulm.de.ORCID http://orcid.org/0000-0002-5519-9171
Nicole DenoixInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Helmholzstraße 8/1, 89081, Ulm, Germany.
Martin WeplerClinic for Anesthesia, Ulm University Medical Center, Ulm, Germany.
Holger GäßlerClinic for Anesthesia and Intensive Care, Bundeswehrkrankenhaus, Ulm, Germany.
David A C MessererInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Helmholzstraße 8/1, 89081, Ulm, Germany.
Clair HartmannClinic for Anesthesia, Ulm University Medical Center, Ulm, Germany.
Thomas DatzmannClinic for Anesthesia, Ulm University Medical Center, Ulm, Germany.
Peter RadermacherInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Helmholzstraße 8/1, 89081, Ulm, Germany.
Oscar McCookInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Helmholzstraße 8/1, 89081, Ulm, Germany.

Funding

Deutsche Forschungsgemeinschaft CRC1149Deutsche Forschungsgemeinschaft GRK 2203
6 · The paper itself

Abstract

This review addresses the plausibility of hydrogen sulfide (H

Indexed as

Gaseous mediatorHypometabolismInflammationOxidative stressSuspended animationTranslational medicine

Identifiers

PMID33336306
PMCPMC7746418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.